口腔及口咽癌新版TNM分期与NCCN诊治指南部分解读

doi:10.19438/j.cjoms.2018.06.010

中国口腔颌面外科杂志 ›› 2018, Vol. 16 ›› Issue (6): 533-546.doi: 10.19438/j.cjoms.2018.06.010

口腔及口咽癌新版TNM分期与NCCN诊治指南部分解读

尚伟^1,2,*, 郑家伟^3,*

1.青岛大学附属医院口腔颌面外科,山东青岛 266003;
2.青岛大学口腔医学院,山东青岛 266003;
3.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科,上海 200011;

收稿日期:2018-08-10 出版日期:2018-11-20 发布日期:2019-01-11
通讯作者: 尚伟,E-mail：liweishang@126.com;郑家伟,E-mail：davidzhengjw@hotmail.com。^*共同通信作者
作者简介:尚伟（1963-）,男,教授,主任医师,博士研究生导师

Interpretation of the new TNM classification and the NCCN guidelines for cancers of the oral cavity and oropharynx

SHANG Wei^1,2, ZHENG Jia-wei³

1.Department of Oral and Maxillofacial Surgery, the Affiliated Hospital of Qingdao University. Qingdao 266003;
2. School of Stomatology, Qingdao University. Qingdao 266003, Shandong Province;
3.Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine. Shanghai 200011, China

Received:2018-08-10 Online:2018-11-20 Published:2019-01-11

摘要/Abstract

摘要： 美国癌症联合委员会《AJCC肿瘤分期手册》与美国国立综合癌症网(NCCN）肿瘤学临床实践指南已广泛用于临床实践中。NCCN肿瘤诊治指南与TNM分期密切相关,指南为不同TNM分期的肿瘤制定了较为详细的诊治标准,作为依据指导临床应用。2017年第8版口腔及口咽癌TNM分期新增了较多内容,如侵袭深度（DOI）、淋巴结外扩展（ENE）、人乳头瘤病毒（HPV）等指标用于了新的分期中,并且为HPV相关的口咽癌制定了一个新的TNM分期。2018年版NCCN口腔与口咽癌指南及时反映了第8版口腔及口咽癌TNM分期中新的变化,同时亦为HPV相关的口咽癌制定了相应的诊治指南。新的TNM分期及NCCN诊治指南对口腔与口咽癌患者诊疗策略的制定及治疗方案的选择具有较大的指导意义。为了临床工作的需要,本文结合两者的变化进行了部分解读。

关键词: AJCC, TNM分期, NCCN, 治疗指南, 口腔癌, 口咽癌

Abstract: The AJCC Cancer Staging Manual and the NCCN Clinical Practice Guidelines in Oncology are widely used in clinical practice. NCCN diagnosis and treatment guidelines are closely related to TNM staging, and the guidelines provide more detailed diagnostic and therapeutic criteria for cancers with different TNM staging as a basis for guiding clinical application. The 8th edition TNM staging system for cancers of the oral cavity and oropharynx introduced a number of significant changes, such as depth of invasion(DOI), extranodal extension (ENE), human papillomavirus(HPV) and other indicators were used in the new stage, and a new chapter describing the staging of HPV-associated oropharyngeal cancers had been added. The 2018 NCCN guidelines for cancers of the oral cavity and oropharynx timely reflected the new changes in the 8th edition TNM staging, and the panel also created separate algorithms for HPV-associated (p16-positive) oropharyngeal cancer. The new TNM staging and NCCN guidelines are of great guiding significance in the treatment strategies and plans for patients with cancers of the oral cavity and oropharynx. The treatment recommendations were provided and the interpretation was made for the needs of clinical practice in this paper.

Key words: AJCC, TNM classification, NCCN, Treatment guideline, Oral cavity cancer, Oropharyngeal, Cancer

中图分类号:

尚伟, 郑家伟. 口腔及口咽癌新版TNM分期与NCCN诊治指南部分解读[J]. 中国口腔颌面外科杂志, 2018, 16(6): 533-546.

SHANG Wei, ZHENG Jia-wei. Interpretation of the new TNM classification and the NCCN guidelines for cancers of the oral cavity and oropharynx[J]. China J Oral Maxillofac Surg, 2018, 16(6): 533-546.

参考文献

[1] Amin MB, Edge SB, Greene FL, et al.AJCC cancer staging manual[M]. 8th Ed. New York: Springer, 2017.
[2] The NCCN clinical practice guidelines in oncology, head and neck cancers[M]. Version 2. National Comprehensive Cancer Network Inc., 2018.
[3] Ebrahimi A, Gil Z, Amit M, et al.Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study[J]. JAMA Otolaryngol Head Neck Surg, 2014, 140(12): 1138-1148.
[4] Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual[J]. CA Cancer J Clin, 2017, 67(2): 122-137.
[5] Ebrahimi A, Clark JR, Amit M, et al.Minimum nodal yield in oral squamous cell carcinoma: defining the standard of care in a multicenter international pooled validation study[J]. Ann Surg Oncol, 2014, 21(9): 3049-3055.
[6] Prabhu RS, Hanasoge S, Magliocca KR, et al.Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection[J]. Cancer, 2014, 120(10): 1499-1506.
[7] Wreesmann VB, Katabi N, Palmer FL, et al.Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma[J]. Head Neck, 2016, 38(Suppl 1): E1192-1199.
[8] Ang KK, Harris J, Wheeler R, et al.Human papillomavirus and survival of patients with oropharyngeal cancer[J]. N Engl J Med, 2010, 363(1): 24-35.
[9] Ebrahimi A, Amit M, Yen TC, et al.Comparison of the American Joint Committee on Cancer NI versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system[J]. Head Neck, 2016, 38(1): 135-139.
[10] Lewis JS Jr, Beadle B, Bishop JA, et al.Human papillomavirus testing in head and neck carcinomas: Guideline from the College of American Pathologists[J]. Arch Pathol Lab Med, 2018, 142(5): 559-597.
[11] Maxwell JH, Thompson LD, Brandwein-Gensler MS, et al.Early oral tongue squamous cell carcinoma: sampling of margins from tumor bed and worse local control[J]. JAMA Otolaryngol Head Neck Surg, 2015, 141(12): 1104-1110.
[12] Hinni ML, Ferlito A, Brandwein-Gensler MS, et al.Surgical margins in head and neck cancer: a contemporary review[J]. Head Neck, 2013, 35(9): 1362-1370.
[13] Brandwein-Gensler M, Smith RV, Wang B, et al.Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma[J]. Am J Surg Pathol, 2010, 34(5): 676-688.
[14] Li Y, Bai S, Carroll W, et al.Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma[J]. Head Neck Pathol, 2013, 7(3): 211-223.
[15] Chinn SB, Spector ME, Bellile EL, et al.Impact of perineural invasion in the pathologically N0 neck in oral cavity squamous cell carcinoma[J]. Otolaryngol Head Neck Surg, 2013, 149(6): 893-899.
[16] Civantos FJ, Zitsch RP, Schuller DE, et al.Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial[J]. J Clin Oncol, 2010, 28(8): 1395-1400.
[17] Alkureishi LW, Ross GL, Shoaib T, et al.Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial[J]. Ann Surg Oncol, 2010, 17(9): 2459-2464.
[18] Govers TM, Hannink G, Merkx MA, et al.Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis[J]. Oral Oncol, 2013, 49(8): 726-732.
[19] D'Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissection in node-negative oral cancer[J]. N Engl J Med, 2015, 373(6): 521-529.

口腔及口咽癌新版TNM分期与NCCN诊治指南部分解读

Interpretation of the new TNM classification and the NCCN guidelines for cancers of the oral cavity and oropharynx

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	赵安玉琢, 石兴莲, 刘欢, 姜健红, 李哲臻, 刘梅. 人工智能在口腔癌早期诊断中的应用研究进展[J]. 中国口腔颌面外科杂志, 2024, 22(5): 493-498.
[2]	高鹏飞, 林洁. 区域神经阻滞技术用于口腔癌缺损皮瓣修复手术的研究进展[J]. 中国口腔颌面外科杂志, 2024, 22(4): 400-403.
[3]	洪磊, 陈伟良. 口腔癌老年患者术后静脉血栓栓塞症的危险因素分析[J]. 中国口腔颌面外科杂志, 2024, 22(3): 233-238.
[4]	王帅, 何杏芳, 王蕴洁, 吴伟勤, 黄秋雨. 非药物干预对口腔癌患者术后谵妄预防效果的系统评价[J]. 中国口腔颌面外科杂志, 2024, 22(3): 279-286.
[5]	周新凯¹,张月影¹,滕晓菊²,邹卫珍²,吴瑞芳². 口腔癌患者二元应对现状及影响因素分析[J]. 中国口腔颌面外科杂志, 2024, 22(2): 170-174.
[6]	陈瑞斌, 陈岚枫. 2011—2017年福建省口腔癌发病及死亡趋势分析[J]. 中国口腔颌面外科杂志, 2024, 22(1): 68-72.
[7]	陈歆旖, 李晨蕾, 秦兴军, 张金凤. 口腔癌患者营养状况变化轨迹及其影响因素分析[J]. 中国口腔颌面外科杂志, 2023, 21(6): 538-547.
[8]	周新凯, 滕晓菊, 张月影. 基于CiteSpace口腔癌患者生存质量研究的可视化分析[J]. 中国口腔颌面外科杂志, 2023, 21(6): 586-592.
[9]	陈玉, 陶明, 雷银富, 吴和梅, 彭晓峰, 苟登群. 口腔癌患者术后肺部感染危险因素的meta分析[J]. 中国口腔颌面外科杂志, 2023, 21(5): 511-517.
[10]	何悦, 陈珩, 安金刚, 郭玉兴, 潘剑, 田磊, 刘冰, 侯劲松, 李劲松, 蒋灿华, 李萌宇, 田臻, 许洁, 朱凌, 孙长伏, 郅克谦, 瞿晴, 宗春琳, 孙晶晶, 张志愿. 药物相关性颌骨坏死临床诊疗专家共识[J]. 中国口腔颌面外科杂志, 2023, 21(4): 313-325.
[11]	李贵忠, 李洁莹, 周凯, 孟宇翔, 王可心, 葛胜优, 宋凯, 冯元勇, 陶月琴, 展晓红, 尚伟. 淋巴结外扩展对口腔鳞癌患者TNM分期及生存预后的影响[J]. 中国口腔颌面外科杂志, 2023, 21(4): 377-383.
[12]	汪子恒, 周韧, 严佳, 张磊, 杨雅琼, 姜虹. 靶向EGFR治疗联合化疗与单纯化疗对口腔癌痛的影响[J]. 中国口腔颌面外科杂志, 2023, 21(3): 225-230.
[13]	王博, 沈月洪, 杨宏宇. 鼻咽癌放化疗后继发舌鳞癌、口咽癌及牙龈癌1例并文献复习[J]. 中国口腔颌面外科杂志, 2023, 21(3): 301-305.
[14]	陈伟良. 延长垂直下斜方肌岛状肌皮瓣修复重建大型头颈部缺损[J]. 中国口腔颌面外科杂志, 2023, 21(1): 1-10.
[15]	周瑜, 翁海燕, 司呈云, 段贤捷, 安星妃, 章礼玉. 第8版TNM分期修订版对早期口腔黏膜鳞癌患者预后及危险分层作用的临床研究[J]. 中国口腔颌面外科杂志, 2022, 20(6): 571-576.